Prevymis Prescribing & Dosing Schedule

Dosage & Administration Drug label Prior authorization Financial assistance Patient education People also ask

Prevymis(letermovir)

PREVYMIS 240 MG in 12 ML Injection

NO BOXED WARNING

Dosage & Administration

* HSCT: 480 mg administered once daily orally or as an intravenous (IV) infusion over 1 hour through 100 days post-HSCT. In patients at risk for late CMV infection and disease, PREVYMIS may be continued through 200 days post-HSCT.
* Kidney Transplant: 480 mg administered once daily orally or as an IV infusion over 1 hour through 200 days post-transplant.
* PREVYMIS injection must be administered through a sterile 0.2 micron or 0.22 micron polyethersulfone (PES) in-line filter.
* Following the completion of PREVYMIS prophylaxis, monitoring for CMV reactivation in HSCT recipients is recommended.
* Dosage Adjustment: If PREVYMIS is co-administered with cyclosporine, the dosage of PREVYMIS should be decreased to 240 mg once daily.
* Do not use PREVYMIS injection with IV bags and infusion set materials containing the plasticizer diethylhexyl phthalate (DEHP).

drug label

Prevymis Prescribing Information

Contact Medical Science Liaison

Report Adverse Event

prior authorization

Prevymis Prior Authorization Resources

Most recent state uniform prior authorization forms

Verified: Jun 26, 2024Arizona - Uniform Prior Authorization Form

Verified: Jun 26, 2024Colorado - Uniform Prior Authorization Form

Verified: Jun 26, 2024Hawaii - Uniform Prior Authorization Form

Verified: Jul 26, 2024Illinois - Uniform Prior Authorization Form

Verified: Jun 26, 2024Indiana - Uniform Prior Authorization Form

Verified: Jun 26, 2024Louisiana - Uniform Prior Authorization Form

Verified: Jun 26, 2024Minnesota - Uniform Prior Authorization Form

Verified: Jun 26, 2024New Hampshire - Uniform Prior Authorization Form

Verified: Jun 26, 2024New Mexico - Uniform Prior Authorization Form

Verified: Jun 26, 2024Oregon - Uniform Prior Authorization Form

Verified: Jun 26, 2024Texas - Uniform Prior Authorization Form

Verified: Jul 07, 2024Washington - Uniform Prior Authorization Form

Verified: Jul 07, 2024Wisconsin - Uniform Prior Authorization Form

Coverage Authorization Request

Coverage Authorization Appeals

Prior Authorization Checklist

Appeals Checklist

Benefits investigation

Merck Access Program Enrollment Form

Merck Access Program Enrollment Form - Online

financial assistance

Prevymis Financial Assistance Options

Copay savings program

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Foundation programs

Merck Access Program Enrollment Form

Merck Access Program Enrollment Form - Online

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and copays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Prevymis Patient Education

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link

Patient toolkit

Patient Brochure

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Side Effects

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Prevymis FAQs

How is the dosage of Prevymis?Prevymis is available in 4 dosages, including 20 mg/ml Injection 12 ml, 20 mg/ml Injection 24 ml, 240 mg Tab and 480 mg Tab

What does Prevymis treat?Prevymis treats

What is Prevymis made of?Prevymis contains letermovir which is a Cytomegalovirus DNA Terminase Complex Inhibitor

How Is Prevymis Administered?Prevymis is administered as a Injectable or Oral Pill

What Are The Prevymis Mechanism Of Action?Prevymis mechanism of action is Cytochrome P450 2C19 Inducers, Cytochrome P450 2C8 Inhibitors, Cytochrome P450 2C9 Inducers, Cytochrome P450 3A Inhibitors, DNA Terminase Complex Inhibitors, Organic Anion Transporting Polypeptide 1B1 Inhibitors or Organic Anion Transporting Polypeptide 1B3 Inhibitors

FAQ Data Source

Dosage & Administration

Dosage & Administration

drug label

Prevymis Prescribing Information

prior authorization

Prevymis Prior Authorization Resources

Most recent state uniform prior authorization forms

Benefits investigation

financial assistance

Prevymis Financial Assistance Options

Copay savings program

Foundation programs

patient education

Prevymis Patient Education

Patient toolkit

people also ask

Prevymis FAQs